CUTANEOUS MELANOMA, STAGE III
Clinical trials for CUTANEOUS MELANOMA, STAGE III explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS MELANOMA, STAGE III trials appear
Sign up with your email to follow new studies for CUTANEOUS MELANOMA, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Melanoma patients get immunotherapy shots directly into tumors before surgery
Disease control Recruiting nowThis study tests whether injecting two immunotherapy drugs (ipilimumab and nivolumab) directly into melanoma tumors before surgery can shrink or eliminate the cancer while causing fewer side effects than standard IV treatment. About 50 adults with stage III melanoma that can be s…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Less surgery may be just as good for advanced melanoma after immunotherapy
Disease control Recruiting nowThis study tests whether removing only the largest affected lymph node (instead of all nearby lymph nodes) after 6 weeks of standard immunotherapy works just as well for stage III melanoma. About 1500 adults with resectable stage IIIB-D melanoma will be randomly assigned to one o…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: NA • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New study aims to decode immunotherapy side effects in melanoma patients
Knowledge-focused Recruiting nowThis study follows 300 adults with stage IIB to IV melanoma who are receiving immune checkpoint inhibitors. Researchers will track 53 different symptoms over time to identify which are most common, severe, and distressing. The goal is to find risk factors linked to worse symptoms…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC